Order Article Reprints

Shehab M, Alrashed F, Alfadhli A, Alotaibi K, Alsahli A, Mohammad H, Cherian P, Al-Khairi I, Alphonse Thanaraj T, Channanath A, et al. Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies. Vaccines. 2021; 9(12):1471. https://doi.org/10.3390/vaccines9121471

Shehab, Mohammad, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al-Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, and et al. 2021. "Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies" Vaccines 9, no. 12: 1471. https://doi.org/10.3390/vaccines9121471

Shehab, M., Alrashed, F., Alfadhli, A., Alotaibi, K., Alsahli, A., Mohammad, H., Cherian, P., Al-Khairi, I., Alphonse Thanaraj, T., Channanath, A., Ali, H., Abu-Farha, M., Abubaker, J., & Al-Mulla, F. (2021). Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies. Vaccines, 9(12), 1471. https://doi.org/10.3390/vaccines9121471